The impact of generic-only drug benefits on patients' use of inhaled corticosteroids in a Medicare population with asthma

BACKGROUND: Patients face increasing insurance restrictions on prescription drugs, including generic-only coverage. There are no generic inhaled corticosteroids (ICS), which are a mainstay of asthma therapy, and patients pay the full price for these drugs under generic-only policies. We examined cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Fung, Vicki, Tager, Ira B, Brand, Richard, Newhouse, Joseph P, Hsu, John
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2488344/
https://www.ncbi.nlm.nih.gov/pubmed/18638405
http://dx.doi.org/10.1186/1472-6963-8-151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2488344/
https://www.ncbi.nlm.nih.gov/pubmed/18638405
http://dx.doi.org/10.1186/1472-6963-8-151

Ejemplares similares